BioCentury
ARTICLE | Clinical News

CellaVision DM1200 regulatory update

December 7, 2009 8:00 AM UTC

FDA granted market clearance for CellaVision's CellaVision DM1200, a diagnostic test to provide a preliminary differential count of peripheral blood. The company plans to launch the product in the U.S...